Trial Profile
Phase I Clinical Trial of Camptothecin-20-O-Propionate Hydrate (CZ48)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2021
Price :
$35
*
At a glance
- Drugs Camptothecin (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- Sponsors Cao Pharmaceuticals
- 22 Jul 2019 Planned End Date changed from 1 Feb 2019 to 1 Feb 2020.
- 22 Jul 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Oct 2019.
- 17 Jul 2018 Planned End Date changed from 1 Jul 2018 to 1 Feb 2019.